Article
CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
BioMed research international - 1 Jan 2014
Chou Ying-Erh, Hsieh Ming-Ju, Chiou Hui-Ling, Lee Hsiang-Lin, Yang Shun-Fa, Chen Tzy-Yen
Abstract excerpt
Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths in Taiwan. CD44, one of the well-known tumor markers, plays an essential role in tumor cell differentiation, invasion, and metastasis. We investigated the CD44 single-nucleotide polymorphisms (SNPs) with environmental risk factors related to HCC susceptibility and clinicopathological characteristics. Six SNPs of CD44 were analyzed using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
